Ironwood Pharmaceuticals Inc (IRWD)

01:57 AM

What are the latest earnings results for Ironwood Pharmaceuticals Inc.Record-breaking capital gains - jammulinksnews.com

01:57 AM

11:42 AM

What catalysts could drive Ironwood Pharmaceuticals Inc. stock higher in 2025Maximize your investment portfolio’s performance - jammulinksnews.com

11:42 AM

06:48 AM

How strong is Ironwood Pharmaceuticals Inc. company’s balance sheetGet timely market insights for better trades - jammulinksnews.com

06:48 AM

05:53 AM

Is Ironwood Pharmaceuticals Inc. stock overvalued or undervaluedRecord-setting profit potential - jammulinksnews.com

05:53 AM

Jul 26, 2025

What makes Ironwood Pharmaceuticals Inc. stock price move sharplyFree Consultation - Metal.it

Jul 26, 2025

Jul 25, 2025

Ironwood Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated capital growth - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

Ironwood Pharmaceuticals Inc: Analyzing IRWD Stock Trends - investchronicle.com

Jul 24, 2025

Jul 23, 2025

What drives Ironwood Pharmaceuticals Inc. stock priceTriple-digit wealth increases - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Ironwood Pharmaceuticals Inc. stockHigh-yield market plays - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Is Ironwood Pharmaceuticals Inc. a good long term investmentRapid portfolio appreciation - jammulinksnews.com

Jul 22, 2025

Jul 17, 2025

How the Irritable Bowel Syndrome (IBS) Treatment Market Will - openPR.com

Jul 17, 2025

Jul 15, 2025

How Ironwood Pharmaceuticals Inc. stock performs during market volatilityTop Gaining Low Risk Assets - Newser

Jul 15, 2025

Jul 15, 2025

Why Ironwood Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Confidence Trade Setups - Newser

Jul 15, 2025

Jul 14, 2025

Endometriosis Pain Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine - The Globe and Mail

Jul 14, 2025

Jul 14, 2025

Endometriosis Pain Pipeline 2025: FDA Updates, Therapy Innovations, And Clinical Trial Landscape Analysis By Delveinsight Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, Abbvie/Neurocrine - MenaFN

Jul 14, 2025

Jul 10, 2025

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY By Investing.com - Investing.com Nigeria

Jul 10, 2025

Jul 10, 2025

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY - Investing.com

Jul 10, 2025

Jul 03, 2025

Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Jul 03, 2025

Jun 30, 2025

Ironwood Pharmaceuticals, Inc.(NasdaqGS: IRWD) added to Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 25, 2025

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Held Back By Insufficient Growth Even After Shares Climb 28% - simplywall.st

Jun 25, 2025

Jun 12, 2025

Ironwood Pharma Elects Directors at Annual Meeting - TipRanks

Jun 12, 2025

Jun 06, 2025

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025

Jun 05, 2025

Ironwood Pharmaceuticals Inc (IRWD) Is A Good Stock To Invest In - Stocksregister

Jun 05, 2025

May 29, 2025

Ameriprise Financial Inc. Trims Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

May 29, 2025

May 28, 2025

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire

May 28, 2025